Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 9/20 | 0.72 |
| ▸ | KDM5A | P29375 | 7/20 | 0.72 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.72 |
| ▸ | KDM5C | P41229 | 1/20 | 0.69 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.69 |
| ▸ | KDM4A | O75164 | 2/20 | 0.67 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.58 |
| ▸ | PPARG | P37231 | 6/20 | 0.58 |
| ▸ | PPARD | Q03181 | 6/20 | 0.58 |
| ▸ | PPARA | Q07869 | 6/20 | 0.58 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.58 |
| ▸ | TSHR | P16473 | 4/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | TLR2 | O60603 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | FABP4 | P15090 | 2/20 | 0.58 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.58 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.58 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8359768 | 1.00 | KDM4C (0.72) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL27622230 | 1.00 | KDM4C (0.72) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL16492835 | 1.00 | KDM4C (0.72) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL11587594 | 1.00 | KDM4C (0.72) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL8341418 | 1.00 | KDM4C (0.72) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL29380393 | 1.00 | KDM4C (0.72) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL5984578 | 1.00 | KDM4C (0.72) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL28434194 | 1.00 | KDM4C (0.72) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL11585238 | 0.98 | KDM4C (0.70) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL4066314 | 0.98 | KDM4C (0.70) | KDM4CKDM5APHF8KDM5CKDM5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1064254-B1 | ALIPHATIC AMINO CARBOXYLIC AND AMINO PHOSPHONIC ACIDS, AMINO NITRILES AND AMINO TETRAZOLES AS CELLULAR RESCUE AGENTS | UNIV SASKATCHEWAN (CA) | 2007-10-17 | — | — | EP | claimed |
| US-6984754-B1 | Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents | UNIVERSITY OF SASKATCHEWAN TECHNOLOGIES INC. (CA) | 2006-01-10 | — | — | US | claimed |
| CN-1213999-C | Aliphatic amino carboxylic and aminophosphonic acids, amino nitriles and amino tetrazoles as cell rescue agents | UNIV OF SASKATCHEWAN TECHNOLOG (CA) | 2005-08-10 | — | — | CN | claimed |
| JP-2002507591-A | — | — | 2002-03-12 | — | — | JP | claimed |
| CN-1299342-A | Aliphatic amino carboxylic and aminophosphonic acids, amino nitriles and amino tetrazoles as cell rescue agents | UNIV OF SASKATCHEWAN TECHNOLOG (CA) | 2001-06-13 | — | — | CN | claimed |
| EP-1064254-A2 | ALIPHATIC AMINO CARBOXYLIC AND AMINO PHOSPHONIC ACIDS, AMINO NITRILES AND AMINO TETRAZOLES AS CELLULAR RESCUE AGENTS | University of Saskatchewan Technologies Inc. (CA) | 2001-01-03 | — | — | EP | claimed |
| WO-1999048858-A2 | ALIPHATIC AMINO CARBOXYLIC AND AMINO PHOSPHONIC ACIDS, AMINO NITRILES AND AMINO TETRAZOLES AS CELLULAR RESCUE AGENTS | UNIVERSITY OF SASKATCHEWAN TECHNOLOGIES INC. (CA) | 1999-09-30 | — | — | WO | claimed |
| EP-1064254-B1 | ALIPHATIC AMINO CARBOXYLIC AND AMINO PHOSPHONIC ACIDS, AMINO NITRILES AND AMINO TETRAZOLES AS CELLULAR RESCUE AGENTS | UNIV SASKATCHEWAN (CA) | 2007-10-17 | — | — | EP | disclosed |
| US-6984754-B1 | Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents | UNIVERSITY OF SASKATCHEWAN TECHNOLOGIES INC. (CA) | 2006-01-10 | — | — | US | disclosed |
| CN-1213999-C | Aliphatic amino carboxylic and aminophosphonic acids, amino nitriles and amino tetrazoles as cell rescue agents | UNIV OF SASKATCHEWAN TECHNOLOG (CA) | 2005-08-10 | — | — | CN | disclosed |
| US-20050159393-A1 | Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents | UNIVERSITY OF SASKATCHEWAN TECHNOLOGIES INC. (CA) | 2005-07-21 | — | — | US | disclosed |
| US-6642223-B2 | A benzoazepin or benzodiazepin derivatives, shows excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as antagonist | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2003-11-04 | — | — | US | disclosed |
| EP-1221440-A1 | Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators | Otsuka Pharmaceutical Company, Limited (JP) | 2002-07-10 | — | — | EP | disclosed |
| WO-1995034540-A1 | BENZOHETEROCYCLIC DERIVATIVES USEFUL AS VASOPRESSIN OR OXYTOCIN MODULATORS | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1995-12-21 | — | — | WO | disclosed |
| EP-0612319-A1 | BENZOHETEROCYCLIC COMPOUNDS AS OXYTOCIN AND VASOPRESSIN ANTAGONISTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-08-31 | — | — | EP | disclosed |
| EP-0602209-A1 | OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-06-22 | — | — | EP | disclosed |
| WO-1994004525-A1 | BENZOHETEROCYCLIC COMPOUNDS AS OXYTOCIN AND VASOPRESSIN ANTAGONISTS | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1994-03-03 | — | — | WO | disclosed |
| WO-1994001113-A1 | OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1994-01-20 | — | — | WO | disclosed |
| EP-0450097-A1 | BENZOHETEROCYCLIC COMPOUNDS. | OTSUKA PHARMA CO LTD (JP) | 1991-10-09 | — | — | EP | disclosed |
| WO-1991005549-A1 | BENZOHETEROCYCLIC COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-05-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050159393-A1 | Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents | CHAMP1, PYCR1, PRMT5 | KDM4C 2590/4885KDM5A 1826/4885PHF8 1328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.